Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity

Neuropharmacology

Volumn 38, Issue 10, 1999, Pages 1621-1630

  Behrens, M Margarita ^a   Strasser, Uta ^a   Heidinger, Valérie ^a   Lobner, Doug ^a   Yu, Shan Ping ^a   McDonald, John W ^a   Won, Michelle ^a   Choi, Dennis W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Glutamate receptors; Neuronal death

Indexed keywords

EGLUMETAD; GLUTAMATE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASTROCYTES; BICYCLO COMPOUNDS; CELL DEATH; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; ISCHEMIC ATTACK, TRANSIENT; MEMBRANE POTENTIALS; MICE; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSFECTION;

EID: 0032834689     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00098-2     Document Type: Article

References (67)

1. Agrawal S.K., Theriault E., Fehlings M.G. Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury. J. Neurotrauma. 15:1998;929-941.
2. Ambrosini A., Bresciani L., Fracchia S., Brunello N., Racagni G. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol. Pharmacol. 47:1995;1057-1064.
3. Aniksztejn L., Bregestovski P., Ben-Ari Y. Selective activation of quisqualate metabotropic receptor potentiates NMDA but not AMPA responses. Eur. J. Pharmacol. 3:1991;327-328.
4. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Rev. 29:1999;83-120.
5. Bond A., Monn J.A., Lodge D. A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740. NeuroReport. 8:1997;1463-1466.
6. Bond A., O'Neill M.J., Hicks C.A., Monn J.A., Lodge D. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport. 20:1998;1191-1193.
7. Bruno V., Copani A., Battaglia G., Raffaele R., Shinozaki H., Nicoletti F. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur. J. Pharmacol. 256:1994;109-112.
8. Bruno V., Copani A., Knöpfel T., Kuhn R., Casabona G., Dell' Albani P., Condorelli D.F., Nicoletti F. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology. 34:1995;1089-1098.
9. Bruno V., Sureda F.X., Storto M., Casabona G., Caruso A., Knopfel T., Kuhn R., Nicoletti F. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J. Neurosci. 17:1997;1891-1897.
10. Bruno V., Battaglia G., Copani A., Casabona G., Storto M., Di Giorgi Gerevini V., Ngomba R., Nicoletti F. Metabotropic glutamate receptors and neurodegeneration. Prog. Brain Res. 116:1998;209-221.
11. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β J. Neurosci. 18:1998;9594-9600.
12. Bruno V., Battaglia G., Kingston A., O'Neill M.J., Catania M.V., Di Grezia R., Nicoletti F. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology. 38:1999;199-207.
13. Buisson A., Choi D.W. Metabotropic glutamate receptor activation attenuates NMDA-induced injury in cortical cell culture. Krieglstein J., Oberpichler-Schwenk H. Pharmacology of Cerebral Ischemia. 1994;109-114 Wissenshaftliche Verlagsgesellschaft mbH, Stuttgart.
14. Buisson A., Choi D.W. The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology. 34:1995;1081-1087.
15. Buisson A., Yu S.P., Choi D.W. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons. Eur. J. Neurosci. 8:1996;138-143.
16. H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. Br. J. Pharmacol. 123:1998;497-504.
17. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
18. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
19. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
20. Contractor A., Gereau R.W. IV, Green T., Heinemann S.F. Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 95:1998;8969-8974.
21. Du C., Hu R., Csernansky C.A., Liu X.Z., Hsu C.Y., Choi D.W. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 718:1996;233-236.
22. East S.J., Hill M.P., Brotchie J.M. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. Eur. J. Pharmacol. 277:1995;117-121.
23. Ferraguti F., Pietra C., Valerio E., Corti C., Chiamulera C., Conquet F. Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity. Neuroscience. 79:1997;1-5.
24. Fitzjohn S.M., Irving A.J., Palmer M.J., Harvey J., Lodge D., Collingridge G.L. Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neurosci. Lett. 26:1996;211-213.
25. Ginsberg M.D., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627-1642.
26. Goldberg M.P., Choi D.W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13:1993;3510-3524.
27. Hayashi Y., Tanabe Y., Aramori I., Masu M., Shimamoto K., Ohfune Y., Nakanishi S. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 107:1992;539-543.
28. Hayashi Y., Sekiyama N., Nakanishi S., Jane D.E., Sunter D.C., Birse E.F., Udvarhelyi P.M., Watkins J.C. Analysis of agonist and antagonist activities of phenylglycine derivates for different cloned metabotropic glutamate receptor subtypes. J. Neurosci. 14:1994;3370-3377.
29. Henrich-Noack P., Hatton C.D., Reymann K.G. The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils. NeuroReport. 20:1998;985-988.
30. Henrich-Noack P., Reymann K.G. (1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia. Eur. J. Pharmacol. 365:1999;55-58.
31. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Watkins J.C. New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord. Neuropharmacology. 34:1995;851-856.
32. Jane D.E., Thomas N.K., Tse H.W., Watkins J.C. Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology. 35:1996;1029-1035.
33. Joly C., Gomeza J., Brabet I., Curry K., Bockaert J., Pin J.P. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci. 15:1995;3970-3981.
34. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
35. Koh J.Y., Palmer E., Cotman C.W. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;9431-9435.
36. Lam A.G.M., Soriano M.A., Monn J.A., Schoepp D.D., Lodge D., McCulloch J. Effects of the metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia. Neurosci. Lett. 254:1998;121-123.
37. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
38. 3H]-aspartate output in rat striatum. Br. J. Pharmacol. 110:1993;1407-1412.
39. Lovinger D.M., McCool B.A. Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3. J. Neurophysiol. 73:1995;1076-1083.
40. McDonald J.W., Roeser N.F., Silverstein F.S., Johnston M.V. Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp. Neurol. 106:1989;289-296.
41. McDonald J.W., Fix A.S., Tizzano J.P., Schoepp D.D. Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J. Neurosci. 13:1993;4445-4455.
42. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
43. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 14:1997;528-537.
44. Monyer H., Giffard R.G., Hartley D.M., Dugan L.L., Goldberg M.P., Choi D.W. Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin. Neuron. 8:1992;967-973.
45. Mukhin A.G., Ivanova S.A., Faden A.I. mGluR modulation of post-traumatic neuronal death: role of NMDA receptors. Neuroreport. 8:1997;2561-2566.
46. Opitz T., Richter P., Reymann K.G. The metabotropic glutamate receptor antagonist (+)-α-methyl-4-carboxyphenylglycine protects hippocampal CA1 neurons of the rat from in vitro hypoxia/hypoglycemia. Neuropharmacology. 33:1994;715-717.
47. Orlando L.R., Standaert D.G., Penney J.B. Jr., Young A.B. Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neurosci. Lett. 202:1995;109-112.
48. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
49. Rauca C., Henrich-Noack P., Schäfer K., Höllt V., Reymann K.G. (S)-4C3HPG reduces infarct size after focal cerebral ischemia. Neuropharmacology. 37:1998;1649-1652.
50. Rainnie D.G., Holmes K.H., Shinnick-Gallagher P. Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala. J. Neurosci. 14:1994;7208-7220.
51. Rose K., Goldberg M.P., Choi D.W. Cytotoxicity in murine cortical cell culture. Tyson C.A., Frazier J.M. In Vitro Biological Methods. Methods in Toxicology. 1993;46-60 Academic Press, San Diego.
52. Sacaan A.I., Schoepp D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 11:1992;77-82.
53. Schaffhauser H., Cartmell J., Jakob-Røtne R., Mutel V. Pharmacological characterization of metabotropic glutamate receptors linked to the inhibition of adenylate cyclase activity in rat striatal slices. Neuropharmacology. 36:1997;933-940.
54. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerman S.L., Burnett J.P., Belegage R., Bleakman D., Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology. 36:1997;1-11.
55. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Monn J.A. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist. Naunym Schmieddeberg Arch. Pharmacol. 358:1998;175-180.
56. Sekiyama N., Hayashi Y., Nakanishi S., Jane D.E., Tse H.W., Birse E.F., Watkins J.C. Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes. Br. J. Pharmacol. 117:1996;1493-1503.
57. Sheardown M.J. Metabotropic glutamate receptor agonists reduce epileptiform activity in the rat cortex. Neuroreport. 3:1992;916-918.
58. Siliprandi R., Lipartiti M., Fadda E., Sautter J., Manev H. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur. J. Pharmacol. 14:1992;173-174.
59. Strasser U., Lobner D., Behrens M.M., Choi D.W. Antagonists for mGluR1 attenuate excitotoxic neuronal death in cortical cultures. Eur. J. Neurosci. 10:1998;2848-2855.
60. Strasser U., Behrens M.M., Choi D.W. The mGluR1 antagonist PHCCC attenuates several forms of excitotoxic neuronal death. Eur. J. Neurosci. (suppl.). 10:1998;204.
61. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:1990;290-293.
62. Tang E., Yip P.K., Chapman A.G., Jane D.E., Meldrum B.S. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur. J. Pharmacol. 327:1997;109-115.
63. Thomsen C., Klitgaard H., Sheardown M., Jackson H.C., Eskesen K., Jacobsen P., Treppendahl S., Suzdak P.D. (S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice. J. Neurochem. 62:1994;2492-2495.
64. Thoreson W.B., Miller R.F. Actions of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) in retinal ON bipolar cells indicate that it is an agonist at L-AP4 receptors. J. Gen. Physiol. 103:1994;1019-1034.
65. Ugolini A., Bordi F. Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrus. Eur. J. Pharmacol. 294:1995;403-410.
66. Yoshino M., Sawada S., Yamamoto C., Kamiya H. A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus. Neurosci. Lett. 207:1996;70-72.
67. Wu S., Wright R.A., Rockey P.K., Burgett S.G., Arnold J.S., Rosteck P.R. Jr., Johnson B.G., Schoepp D.D., Belagaje R.M. Group III human metabotropic glutamate receptors 4,7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Mol. Brain Res. 53:1998;88-97.